Effects of Oliceridine Versus Sufentanil on Hemodynamic Stability in Elderly Hypertensive Patients During Laryngeal Mask Airway Anesthesia: A Randomized Controlled Trial
Drug Design, Development and Therapy · 2025
DOI: 10.2147/dddt.s547901 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Lvlv Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, People's Hospital of Qiannan, Duyun, 558000, People's Republic of China. Hauptthemen laut MEDLINE: Hemodynamics, Hypertension, Laryngeal Masks, Sufentanil. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, People's Hospital of Qiannan, Duyun, 558000, People's Republic of China.
- Department of Anesthesiology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 330300, People's Republic of China.
Zitieren
APA
Chen, L., Xie, K., Ji, K., Long, M., Zhang, Y., & He, K. (2025). Effects of Oliceridine Versus Sufentanil on Hemodynamic Stability in Elderly Hypertensive Patients During Laryngeal Mask Airway Anesthesia: A Randomized Controlled Trial. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s547901
Vancouver
Chen L, Xie K, Ji K, Long M, Zhang Y, He K. Effects of Oliceridine Versus Sufentanil on Hemodynamic Stability in Elderly Hypertensive Patients During Laryngeal Mask Airway Anesthesia: A Randomized Controlled Trial. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s547901
BibTeX
@article{Chen2025,
author = {Chen, Lvlv and Xie, Kangjie and Ji, Kuiquan and Long, Mingbo and Zhang, Yongguo and He, Kai},
title = {Effects of Oliceridine Versus Sufentanil on Hemodynamic Stability in Elderly Hypertensive Patients During Laryngeal Mask Airway Anesthesia: A Randomized Controlled Trial},
journal = {Drug Design, Development and Therapy},
year = {2025},
doi = {10.2147/dddt.s547901}
}
EUVIMED